<DOC>
	<DOCNO>NCT01160263</DOCNO>
	<brief_summary>The purpose study study transporter serotonin dopamine ALS patient relation clinical phenotype , i.e. , patient without stiffness , patient pyramidal stiffness , patient mixed ( pyramidal extra pyramidal ) stiffness . For goal investigator use SPECT compare bind two specific tracer ALS patient match healthy control .</brief_summary>
	<brief_title>Study Dopamine Serotonin Transporters Patients With Amyotrophic Lateral Sclerosis Controls</brief_title>
	<detailed_description>Study design This study prospective cross-sectional control multicentric clinical study 60 ALS patient 20 control . Three cohort 20 ALS patient ( patient without stiffness , patient pyramidal stiffness , patient mixed pyramidal extra pyramidal stiffness ) 20 healthy control include study Study centre 40 ALS patient 13 control include Paris ALS center , 20 ALS patient 7 control include Tours ALS center . MRI perform Neuroradiology department salpetriere hospital ( Paris ) Bretonneau hospital ( Tours ) SPECT do nuclear medicine center hospital ( Paris- Tours ) . Study duration Per patient control , study last one month . The total study duration two year</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>1 . Patients ( men woman ) 39 ( exclusive ) 66 ( inclusive ) year old sporadic ALS , define , probable laboratory possible disease duration 3 month ( inclusive ) 5 year ( exclusive ) treat rilutek 100 mg/ day since least 1 month 2 . Patients assign three group relation clinical phenotype : 20 patient without stiffness 20 patient pyramidal stiffness ( spasticity patient ) . 20 patient mixed stiffness ( spasticity rigidity ) . 3 . Patients capable thoroughly understand information give ; sign informed consent form ( signature spouse family relative acceptable third party acceptable patient physically unable sign ) . 4 . To social insurance 1 . Patients FRONTO temporal dementia ( accord NEARY ' criterion ) 2 . Patients concomitant lifethreatening disease disease impairment likely interfere functional assessment ; 3 . Patients major evolve psychiatric disorder major anxiety disorder accord DSMIV criterion ( APA , 1996 ) 4 . Patients receive treatment could interfere serotonin dopamine metabolism 5 . Patients contraindication datscan /or ADAM scan 6 . Patients contraindication MRI scan . 7 . Patients previous vascular , traumatic tumoral cerebral lesion make impossible quantification tracer 8 . Patients cancer within past 5 9 . Patients child bearing , breast feed second part cycle without efficient contraceptive device treatment 10 . Patients liable cooperative comply trial requirement ( assessed investigator ) , unable reach event emergency ;</criteria>
	<gender>All</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>ALS</keyword>
	<keyword>serotonin</keyword>
	<keyword>dopamine</keyword>
</DOC>